Biol Sex Differ:基础的和临床前的年龄相关听力损失研究的性别偏差分析

2018-06-21 AlexYang MedSci原创

最近,有研究人员确定了2006年到2015年10年之间,是否在关于年龄相关听力损失的基础和临床前研究中存在性别偏差,这要比NIH授权将性别包括在生物变量中的时间-2016年要更早。研究人员在PubMed中搜索了"年龄相关听力损失"关键词的相关文章,时间为2006年到2015年。研究只包括了原始研究(不包括综述或者元分析),并且是英语文章,包括摘要,使用动物模型且是主要与年龄相关听力损失相关。上述标

最近,有研究人员确定了2006年到2015年10年之间,是否在关于年龄相关听力损失的基础和临床前研究中存在性别偏差,这要比NIH授权将性别包括在生物变量中的时间-2016年要更早。

研究人员在PubMed中搜索了"年龄相关听力损失"关键词的相关文章,时间为2006年到2015年。研究只包括了原始研究(不包括综述或者元分析),并且是英语文章,包括摘要,使用动物模型且是主要与年龄相关听力损失相关。上述标准总共筛选出了231篇文章。其中,每篇文章研究人员都筛选了动物的性别、雄性动物和雌性动物的数量、基于性别的讨论、研究的地点和出版的年份。研究发现,只有三分之二的文章报道了试验中动物的性别,其中有54%的具有两种性别,34%的研究只用雄性,13%的研究只用雌性。在那些报道了性别和动物数量的文章中,67%为雄性,33%为雌性。与在美国的研究相比,雄性动物使用的数量是国际研究的2倍以上。另外,在所有的文章中,只有15%讨论了基于性别的结果。

最后,研究人员指出,2006年到2015年之间的文章在基础和临床前年龄相关听力损失研究中存在性别偏差。雌性和雄性在基础和临床前年龄相关听力损失研究中的同时存在对理解基于性别的机制差异和有效治疗方法的选择方面非常关键。

原始出处:

Villavisanis DF, Schrode KM, Lauer AM et al. Sex bias in basic and preclinical age-related hearing loss research. Biol Sex Differ. 13 June 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1784211, encodeId=dff11e8421108, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Aug 18 17:31:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933447, encodeId=f28c193344ef4, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat Oct 13 17:31:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918126, encodeId=26bb1918126df, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Jul 02 20:31:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767460, encodeId=94cf1e67460ed, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jun 30 15:31:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306220, encodeId=7b95130622015, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Jun 23 11:31:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
    2018-08-18 isabellayj
  2. [GetPortalCommentsPageByObjectIdResponse(id=1784211, encodeId=dff11e8421108, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Aug 18 17:31:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933447, encodeId=f28c193344ef4, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat Oct 13 17:31:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918126, encodeId=26bb1918126df, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Jul 02 20:31:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767460, encodeId=94cf1e67460ed, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jun 30 15:31:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306220, encodeId=7b95130622015, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Jun 23 11:31:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1784211, encodeId=dff11e8421108, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Aug 18 17:31:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933447, encodeId=f28c193344ef4, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat Oct 13 17:31:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918126, encodeId=26bb1918126df, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Jul 02 20:31:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767460, encodeId=94cf1e67460ed, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jun 30 15:31:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306220, encodeId=7b95130622015, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Jun 23 11:31:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
    2018-07-02 仁心济世
  4. [GetPortalCommentsPageByObjectIdResponse(id=1784211, encodeId=dff11e8421108, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Aug 18 17:31:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933447, encodeId=f28c193344ef4, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat Oct 13 17:31:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918126, encodeId=26bb1918126df, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Jul 02 20:31:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767460, encodeId=94cf1e67460ed, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jun 30 15:31:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306220, encodeId=7b95130622015, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Jun 23 11:31:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1784211, encodeId=dff11e8421108, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Aug 18 17:31:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933447, encodeId=f28c193344ef4, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat Oct 13 17:31:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1918126, encodeId=26bb1918126df, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Jul 02 20:31:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767460, encodeId=94cf1e67460ed, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jun 30 15:31:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306220, encodeId=7b95130622015, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Jun 23 11:31:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]

相关资讯

Int J Pediatr Otorhinolaryngol:患有感官听力损失儿童和青少年平衡表现分析

之前的一些研究阐释了在感官听力损失(SNHL)儿童中听力损失程度与前庭功能障碍之间的平行关系。尽管如此,关于听力损失程度的反应和平衡表现的致病因素仍旧所知甚少。最近,有研究人员比较了正常听力(NH)儿童和那些具有SNHL儿童的平衡表现,并且考虑了性别、年龄范围,还根据听力损失程度和致病因素分析了平衡表现。研究包括了96名儿童(48名NH,48名SNHL),年龄在7到18岁之间。研究发现,与NH组比

Int J Tuberc Lung Dis:在HIV共感染的MDR-TB患者中,氨基糖苷类诱导的听力损失风险增加

多重抗药性结核病(MDR-TB)患者中很高比例由于注射氨基糖苷类(AGs)引起的耳毒性从而发展为永久性听力损失。AG诱导的听力损失在结核病(TB)和人类免疫缺陷病毒(HIV)流行的撒哈拉以南非洲国家中的流行程度是最高的。然而,在MDR-TB治疗期间,是否HIV共感染与更高的AG诱导的听力损失相关仍旧存在争议。最近,有研究人员在MDR-TB患者中,评估了HIV共感染对AG诱导的听力损失的影响。研究人

JAMA Otolaryngol Head Neck Surg:老年人中心血管并发症与听力损失相关性研究

最近,有研究人员调查了心血管疾病(CVD)相关风险因子与听觉功能在老年人(>80岁)中的相关性。研究发现,在433名患者中(67%为女性;平均(SD)年龄:89 [5.8] 岁)。与平均(SD)低频率纯音均值(LFPTA)为36.9(3.5)分贝听力损失(dB HL)相比,至少存在一种心血管并发症的患者与提高的LFPTA 42.4(1.6)相关,两者的LFPTA差异为5.47(95% CI,

Disabil Rehabil:重度到永久听力损伤的人口数据、性别差异和听觉康复益处分析

最近,有研究人员鉴定了报道了重度到永久听力损失患者的人口数据,评估了听觉康复参与的益处并且分析了各种听力重建方法的优势。研究包括了4286名患有重度到永久性听力损伤患者的数据,研究人员分析了他们的人口数据情况、性别差异、听力康复和康复的益处等数据。研究发现,在听觉康复中,团体康复和拜访听力康复教育者能够获得最大的益处。只有40.5%的患者获得了扩展听觉康复,其中的54.5%为女性。另外,总共有9.

Neurosurgery:通过中颅窝的方法对颞骨缺陷的修复研究

颞骨开裂(TBD)经常导致脑脊液(CSF)的泄露和/或者脑突出。TBD同样能够在上半规管中发生,从而引起使人感觉衰弱的眩晕。上述两种发病起因均可通过外科手术修复,但是传统的治疗只关注其中之一。最近,有研究人员报道了他们通过中颅窝(MCF)的方法对颞骨缺陷的修复的经历。研究包括了总共经历37场外科手术的34名患者。肥胖占比高,其中21名患者(61.8%)为肥胖(BMI>30kg/m2),7名(

Hum Genet:PDE1C基因中的显性变异与非综合征听力损失相关

由于遗传的异质性,鉴定引起非综合征听力损失(NSHL)的相关基因变异是非常有挑战的。困难包括了技术上的限制,即在过去由于技术的限制阻碍了综合的基因鉴定。最近在技术的的进展,比如利用靶标捕获和二代测序技术(NGS)正在改变基因鉴定的现状,并且能够快速和有效的得到全人类外显子组测序结果。最近,有研究人员鉴定了一个5代同堂的中国家庭,伴随有进展性的、后听觉常染色体显性非综合征听力损失(ADNSHL)。研